Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
about
Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation.Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs.Side effects and medication adherence of tyrosine kinase inhibitors for patients with chronic myeloid leukemia in Taiwan.
P2860
Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Treatment adherence in chronic ...... ing tyrosine kinase inhibitors
@ast
Treatment adherence in chronic ...... ing tyrosine kinase inhibitors
@en
type
label
Treatment adherence in chronic ...... ing tyrosine kinase inhibitors
@ast
Treatment adherence in chronic ...... ing tyrosine kinase inhibitors
@en
prefLabel
Treatment adherence in chronic ...... ing tyrosine kinase inhibitors
@ast
Treatment adherence in chronic ...... ing tyrosine kinase inhibitors
@en
P2093
P2860
P50
P1433
P1476
Treatment adherence in chronic ...... ing tyrosine kinase inhibitors
@en
P2093
Adam Hołub
Ewa Lech-Marańda
Ilona Seferyńska
Piotr Jerzmanowski
Urszula Tęgowska
Violetta Kalinowska
Zofia Specht-Szwoch
P2860
P2888
P356
10.1007/S12032-017-0958-6
P577
2017-04-25T00:00:00Z
P6179
1085054259